About Altos Labs
Altos Labs is a Healthcare company based in San Carlos (United States) founded in 2018 by Benedetta Di Robilant, and was acquired by Altos Labs in May 2025. Altos Labs is focused on restoring cell health through rejuvenation. It operates on a HealthTech model. Altos Labs has raised $150 thousand across 2 funding rounds from investors including HHS, Altos Labs and Y Combinator. The company has 9 employees. Altos Labs offers products and services including Cellular Rejuvenation Programming. Its focus areas include Biotechnology and Cellular Therapy. Its legal entity is Altos Labs, Inc. Its competitors include Moderna, Forge Biologics and Poseida Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Altos Labs is dedicated to advancing cellular rejuvenation programming to reverse disease, injury, and disabilities. Research is conducted to understand deep biology and translate scientific breakthroughs into transformative medicine. The company operates in the biotechnology sector, fostering a collaborative culture across diverse disciplines to enhance human health outcomes.
- Headquarters San Carlos, United States
- Employees 9
- Founders Benedetta Di Robilant
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website doriantherapeutics.com
- Social LinkedIn X
- Acquired by Altos Labs (May 2025)
- Legal Name Altos Labs, Inc.
- Total Equity Funding$150K (USD)
in 2 rounds
- Latest Funding Round$335.65K (USD), Grant
Sep 2021
- InvestorsHHS
& 2 more
- Employee Count9
- Acquired byAltos Labs
(May 2025)
Products & Services of Altos Labs
Altos Labs offers a comprehensive portfolio of products and services, including Cellular Rejuvenation Programming.
Cellular health is restored to reverse disease effects.
Funding Insights of Altos Labs
Altos Labs has successfully raised a total of $150K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $335.65 thousand completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $150,000
- Total Rounds 2
- Last Round Grant — $335,648
- First Round $150,000
(Jun 2018)
- Investors Count 2
All 2 funding rounds of Altos Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2021 | $335,648 | Grant | – | – | |
| Jun 2018 | $150,000 | Seed | – | Y Combinator | – |
3 investors in total: 3 institutional.
Investors in Altos Labs
Altos Labs has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Altos Labs and Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage startups are accelerated via funding and educational programs. | ycombinator.com | Mountain View, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Lab conducting research on cellular rejuvenation programming to restore cell health and resilience | 2017 | altoslabs.com | Redwood City, United States |
Investor details for Altos Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Altos Labs
4 people are tracked at Altos Labs (3 in leadership, 1 in team); the tracked headcount is 9.
| Name | Role | Group |
|---|---|---|
Benedetta Di Robilant | Co-Founder | Leadership |
Maddalena Adorno | Co-Founder and CEO | Leadership |
Sean Brown | VP of Chemistry | Leadership |
Emilie Besnard, PhD | Principal Scientist | Team |
Complete people profiles for Altos Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Altos Labs
4 dated milestones of Altos Labs across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Altos Labs is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Grant, of $336K.
- Exit Acquired by Altos Labs.
Competitors of Altos Labs
Altos Labs has 3 listed competitors in our database, 3 of them funded. They include Moderna, Forge Biologics and Poseida Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| forgebiologics.com | 2020 | Columbus, United States | $250M | 118 | Gene therapies for rare diseases are developed to treat patients. | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies |
Detailed competitors of Altos Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Diabetes
3 companies that operate in the same segment as Altos Labs (Diabetes) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Altos Labs
Complete news archive for Altos Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Altos Labs
Altos Labs was founded in 2018.
Altos Labs is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
Altos Labs is a funded company, having raised a total of $150K across 2 funding rounds to date. The company's 1st funding round was a Seed of $150K, raised on Jun 2018.
Altos Labs has 9 employees.
Altos Labs is dedicated to advancing cellular rejuvenation programming to reverse disease, injury, and disabilities. Research is conducted to understand deep biology and translate scientific breakthroughs into transformative medicine. The company operates in the biotechnology sector, fostering a collaborative culture across diverse disciplines to enhance human health outcomes.
Altos Labs's top competitors include Moderna, Forge Biologics and Poseida Therapeutics.
Altos Labs offers Cellular Rejuvenation Programming.
Altos Labs has 3 investors. Key investors include HHS, Altos Labs, and Y Combinator.
Altos Labs operates through Altos Labs, Inc..
Yes. Altos Labs was acquired by Altos Labs in May 2025.